Trial intelligence / Profile preview

Pegasys pilot study in chronic hepatitis B after prior antiviral treatment failure

ChiCTR-ONRC-05000623Phase 4Completed

Sponsor
Roche
Start
Apr 2005
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of interferon alfa in Chronic Hepatitis B (CHB) (2 arms), sponsored by Roche. Primary endpoints: HBeAg-positive response and HBeAg-negative response. Started Apr 2005; status: completed.

02

Drugs

interferon alfa
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on ChiCTR-ONRC-05000623.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONRC-05000623.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call